Vitamin C and Iron: study protocols
46 study groups took Vitamin C together with Iron. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin C
46 study groups in 32 studies say how much Vitamin C participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 50 mg to 100 mg, 26% of 46 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg or less | 1 |
| 5 mg to 10 mg | 2 |
| 10 mg to 25 mg | 8 |
| 25 mg to 50 mg | 10 |
| 50 mg to 100 mg | 12 |
| 100 mg to 250 mg | 4 |
| 250 mg to 500 mg | 7 |
| over 500 mg | 2 |
Dose per serving from research: Iron
43 study groups in 29 studies say how much Iron participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 5 mg to 10 mg and 100 mg to 250 mg, 23% of 43 study groups each.
| Daily dose | Study groups |
|---|---|
| 1 mg to 2.5 mg | 4 |
| 2.5 mg to 5 mg | 3 |
| 5 mg to 10 mg | 10 |
| 10 mg to 25 mg | 9 |
| 25 mg to 50 mg | 4 |
| 50 mg to 100 mg | 3 |
| 100 mg to 250 mg | 10 |
Commonly used together
23 of 46 study groups took Vitamin C and Iron with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin A | 12 |
| Zinc | 11 |
| Folic Acid | 10 |
| Vitamin E | 5 |
| Copper | 4 |
| Selenium | 4 |
| Vitamin B12 | 3 |
46 study groups
| Study | ||||
|---|---|---|---|---|
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · weekly supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 14.3 mg | 17.1 mg | — | 149 |
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · daily supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 100 mg | 60 mg | — | 143 |
| Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers 2006 · Fortified milk (FM) · Healthy, low-income children aged 10–30 months | 48 mg | 5.8 mg | 26 weeks | — |
| Investigating the preventive effect of vitamins C and E on preeclampsia in nulliparous pregnant women 2020 · intervention group · Nulliparous pregnant women aged 18–38 years without risk factors for preeclampsia | 1 g | — | — | — |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · iron-MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 30 mg | 12.5 mg | 150 days | 967 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 40.2 mg | 9.6 mg | 1 year | 316 |
| Regular vitamin C supplementation during pregnancy reduces hospitalization: outcomes of a Ugandan rural cohort study 2010 · Vitamin C group · Pregnant women aged at least 18, enrolled at 4–12 gestational weeks in Uganda | 400 mg | 200 mg | — | 187 |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 50 mg | 18 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 100 mg | — | — | — |
| Maternal iron deficiency anemia affects postpartum emotions and cognition 2005 · daily iron · Young postpartum mothers with iron-deficiency anemia; age range not stated | 25 mg | 125 mg | 26 weeks | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 40.2 mg | 9.6 mg | 1 year | 316 |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group II · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 500 mg | 6 mg | 9 weeks | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group IV · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 500 mg | 6 mg | 9 weeks | — |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group B · Healthy adult volunteers; sex and age range not stated | 260 mg | 14 mg | 12 weeks | 20 |
| Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo? 2000 · 260 mg/d ascorbate plus 14 mg/d iron · 20 healthy subjects | 260 mg | 14 mg | 6 weeks | — |
| Vitamin C-Rich Guava Consumed with Mungbean Dal Reduces Anemia and Increases Hemoglobin but not Iron Stores: A Randomized Controlled Trial of Food-to-Food Fortification in Indian Children 2024 · mungbean dal with fresh guava · Children aged 6–10 years in rural Haryana, India; the group included children with and without anemia or iron deficiency | 170 mg | 3.2 mg | 213 days | — |
| The effect of iron-vitamin C co-supplementation on biomarkers of oxidative stress in iron-deficient female youth 2013 · 50 mg/day elemental iron + 500 mg/day ascorbic acid · Iron-deficient, non-anemic girls | 500 mg | 50 mg | 12 weeks | — |
| Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial 2020 · intervention group · Adults aged 18–80 undergoing elective hip or knee replacement | 70 mg | 30 mg | 30 days | 37 |
| Iron deficiency in young basketball players: Is a 100 μg/L ferritin cut-off appropriate for iron supplementation?: Results of a randomized placebo-controlled study 2023 · iron supplementation group · male basketball players under 19 years with ferritin below 100 μg/L | 30 mg | 160 mg | 90 days | 26 |
| Oral use of iron with vitamin C in hemodialyzed patients 2003 · Sorbifer Durules · Adults with end-stage renal disease receiving hemodialysis and recombinant human erythropoietin | 60 mg | 100 mg | 4 weeks | 24 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron plus ascorbic acid · Non-anaemic female volunteers | 15 mg | 3.75 mg | 2 days | 20 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 2) · Infants; age and health status not reported | 25 mg | 2.5 mg | 4 days | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 50 mg ascorbic acid (study 2) · Infants; age and health status not reported | 50 mg | 2.5 mg | 4 days | 9 |
| A single high dose of ascorbic acid and iron is not correlated with oxidative stress in healthy volunteers 2008 · 2 g of AA plus 150 mg of iron carbonyl · Healthy, nonsmoking men aged 20–31 years | 2 g | 150 mg | 1 day | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferric pyrophosphate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 25 mg | 2.5 mg | 4 days | 8 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 25 mg | 2.5 mg | 4 days | 8 |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Chromagen · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 200 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Feosol · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 200 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Niferex · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 200 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Tabron · Dialysis patients receiving recombinant human erythropoietin | 100 mg | 200 mg | 26 weeks | — |
| The bioavailability to humans of ascorbic acid from oranges, orange juice and cooked broccoli is similar to that of synthetic ascorbic acid 1993 · Ascorbic acid tablets with iron · Male non-smokers; age and health status not specified | 108 mg | — | 8 weeks | — |
| The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women: A randomized clinical trial 2021 · Lp group · Healthy, non-anemic pregnant women aged 18–42 years, with singleton pregnancies and iron-replete status at enrollment | 24 mg | 8.4 mg | — | 120 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Non-liposomal multivitamin (NL) · Healthy males and females aged 18–65 years | 110 mg | 9 mg | 1 day | 34 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Liposomal multivitamin (L) · Healthy males and females aged 18–65 years | 110 mg | 9 mg | 1 day | 34 |
| Micronutrient deficiency in obese subjects undergoing low calorie diet 2012 · LCD intervention group (low-calorie formula diet) · Adults with obesity (BMI ≥30 kg/m²), men and women; age approximately 47 years on average | 100 mg | 20 mg | 12 weeks | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group II · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 100 mg | 200 mg | 30 days | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group III · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 500 mg | 200 mg | 30 days | 32 |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group A · Healthy adult volunteers; sex and age range not stated | 60 mg | 14 mg | 12 weeks | 20 |
| Short-term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial 2006 · daily group · Children aged 3–6 years in a kindergarten in northern China | 50 mg | 30 mg | 13 weeks | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · daily supplementation group · female Indonesian high-school adolescents | 60 mg | 60 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (60 mg Fe) · female Indonesian high-school adolescents | 8.57 mg | 8.57 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (120 mg Fe) · female Indonesian high-school adolescents | 8.57 mg | 17.1 mg | 90 days | — |
| Micronutrient Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and nutrition program in rural Haiti 2007 · Sprinkles-WSB (S-WSB) · Children aged 9–24 months in rural Haiti receiving take-home fortified wheat-soy blend rations | 30 mg | 12.5 mg | 60 days | 254 |
| Efficacy and safety of emulsified microsomal ferric pyrophosphate vs. Ferrous Ascorbate in pregnancy with iron-deficiency anemia- a randomized, comparative study 2025 · Group A (test) · Pregnant women aged 20–35 years, at 13–16 weeks’ gestation, with iron-deficiency anemia (hemoglobin 9–10.5 g/dL and serum ferritin <15 mcg/L) | 50 mg | 27 mg | 4 weeks | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · daily group · children aged 6–24 months in Vietnam | 20 mg | 8 mg | 90 days | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · weekly group · children aged 6–24 months in Vietnam | 2.86 mg | 2.86 mg | 90 days | 54 |